A new study led by Harvard researchers models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments.

Harvard specialists say COVID-19 pills may cut hospitalizations and deaths and offer big boost to nations struggling with low vaccination rates.

Can the current crop of vaccines get us to herd immunity even if variants become widespread? A Harvard immunologist says yes.